Scientific Founders and Advisors

Scientific Founders of ReproCELL

Norio Nakatsuji, Ph.D. Director, Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto University Norio Nakatsuji, Ph.D.
Director, Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto University


【Career】
Founding director and professor of Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS)
Director and professor at Institute for Frontier Medical Sciences at Kyoto University
Professor at National Institute of Genetics
Principal investigator at the Meiji Institute of Health Science
Postdoctoral training at Umea University in Sweden, Massachusetts Institute of Technology and George Washington University in the USA, and MRC Mammalian Development Unit in UK.
Ph.D. from Graduate School of Science, Kyoto University
Hiromitsu Nakauchi, M.D., Ph.D., Director, Center for Stem Cell and Regenerative Medicine, Institute of Medical Science, The University of Tokyo Hiromitsu Nakauchi, M.D., Ph.D.
Director, Center for Stem Cell and Regenerative Medicine, Institute of Medical Science, The University of Tokyo


【Career】
Director and professor, Center for Stem Cell and Regenerative Medicine, Institute of Medical Science, The University of Tokyo
Professor, Institute of Basic Medical Sciences, University of Tsukuba
RIKEN
Faculty of Medicine, Juntendo University
Stanford University
M.D. and Ph.D. from Graduate School of Medicine, The University of Tokyo

Scientific Advisors of ReproCELL

Atsushi Iwama, M.D., Ph.D. Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University Atsushi Iwama, M.D., Ph.D.
Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University


【Career】
Professor at Graduate School of Medicine, Chiba University
Lecturer at Institute of Medical Science, The University of Tokyo
Lecturer at Tsubuka University Faculty of Medicine
Research fellow at Harbard University
Faculty of Medicine, Kumamoto University
Jichi Medical University Hospital
Niigata University Hospital
M.D. Ph.D. from Faculty of Medicine, Niigata University
Takashi Tada, Ph.D., Associate Professor at Institute for Frontier Medical Sciences, Kyoto University Takashi Tada, Ph.D.
Associate Professor at Institute for Frontier Medical Sciences, Kyoto University


【Career】
Associate Professor at Institute for Frontier Medical Sciences, Kyoto University
Assistant Professor at Institute for Frontier Medical Sciences, Kyoto University
Assistant Professor at National Institute of Genetics
Research Associate at Wellcome CRC (Gurdon) Institute, Cambridge University
Ph.D. from Graduate School of Science, Hokkaido University
Hirofumi Suemori, Ph.D., Associate Professor at Institute for Frontier Medical Sciences, Kyoto University Hirofumi Suemori, Ph.D.
Associate Professor at Institute for Frontier Medical Sciences, Kyoto University


【Career】
Associate Professor at Institute for Frontier Medical Sciences, Kyoto University
Research Associate at Institute for Frontier Medical Sciences, Kyoto University
Research Fellow at Kanagawa Academy of Science and Technology
Ph.D. from Nagoya University
Research Fellow at the Meiji Institute of Health Science
BSc from Faculty of Science, Kyoto University
Taeko Naruse, Ph.D., Medical Research Institute, Tokyo Medical and Dental University Taeko Naruse, Ph.D.
Medical Research Institute, Tokyo Medical and Dental University


【Career】
Assistant Professor at Medical Research Institute, Tokyo Medical and Dental University
Research Fellow at Faculty of Medicine, Tokai University
Research Fellow at Graduate School of Medicine
Ph.D. from Graduate School of Medicine, Osaka City University
Research Fellow at Graduate School of Medicine
Professor Sian E Harding Professor Sian E Harding
Sian Harding is Professor of Cardiac Pharmacology at the National Heart and Lung Institute, Imperial College.


【Career】
She obtained her Ph.D. in Pharmacology from King’s College, London in 1981, and since then the primary focus of her work has been cardiomyocyte function in the failing heart. This has extended to gene therapy to modulate cardiomyocyte function, and she is Scientific PI for the UK’s first clinical trial on myocardial gene therapy. More recently the scope has extended to the characterisation of cardiomyocytes derived from embryonic stem cells, and their use in cardiac repair, tissue engineering and drug discovery.
Professor Harding is Past-President of the European Section of the International Society for Heart Research and Fellow of the AHA, ESC and ISHR. She sits on the Nuffield Council on Bioethics and the Scientific Advisory Board of the PPP “Stem Cells for Safer Medicines”.